Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
3045 participants
INTERVENTIONAL
2019-04-01
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Upon informed consent screening will be performed using whole capillary blood (finger prick testing) with three different tests for HCV Ab, HBsAg and HIV. Screening will be performed first. While awaiting the test result (15-20min), the participant can fill out a questionnaire (together with the study nurse), concerning risk factors for HCV, HBV and HIV infection. This questionnaire is filled out directly online, and will be immediately implemented in the encoded database. The database is set-up according to the rules of good clinical practice. (Castor EDC software). The results will be filled out immediately by the prison staff in this database after it is filled out by the participant, minimizing the risk of displacement of test results.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hepatitis B Virus Prevalence and Risk Factors in Belgium
NCT03425513
Hepatitis B Prevalence in the Turkish Population Living in Middle Limburg
NCT03396458
Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity
NCT02148562
Preliminary Validation of an in Vitro Diagnosis-medical Device for Hepatitis B Screening
NCT04109625
Determination of HCV Prevalence in a HIV Patient Cohort in Phnom Penh, Cambodia
NCT02361541
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
persons in prison
Prevalence of blood borne viral infections (HBV/HCV/HIV)
rapid finger prick test for HCV Ab, HBsAg and HIV and a questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prevalence of blood borne viral infections (HBV/HCV/HIV)
rapid finger prick test for HCV Ab, HBsAg and HIV and a questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Imprisoned in one of the predefined prisons in Flanders Brussels or Wallonia participating in this trial
* Written informed consent obtained
Exclusion Criteria
* Already participated in the study: re-entry within inclusion period in one of the prisons
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Ghent
OTHER
Hasselt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Geert Robaeys
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Geert Robaeys, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hasselt University
Dana Busschots, drs.
Role: STUDY_CHAIR
Hasselt University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Gent
Ghent, , Belgium
Hasselt University
Hasselt, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Busschots D, Kremer C, Bielen R, Koc OM, Heyens L, Brixko C, Laukens P, Orlent H, Bilaey P, De Smet F, Hellemans G, Muyldermans G, Van Baelen L, Hens N, Van Vlierberghe H, Robaeys G. A multicentre interventional study to assess blood-borne viral infections in Belgian prisons. BMC Infect Dis. 2021 Jul 27;21(1):708. doi: 10.1186/s12879-021-06405-z.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HBV-HCV-HIV-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.